{"id":105228,"date":"2022-05-16T09:14:31","date_gmt":"2022-05-16T14:14:31","guid":{"rendered":"https:\/\/www.nationaldrugscreening.com\/?p=105228"},"modified":"2022-05-16T13:35:54","modified_gmt":"2022-05-16T18:35:54","slug":"doj-issues-new-guidance-on-employees-with-opioid-use-disorder","status":"publish","type":"post","link":"https:\/\/www.nationaldrugscreening.com\/blogs\/doj-issues-new-guidance-on-employees-with-opioid-use-disorder\/","title":{"rendered":"DOJ issues new guidance on employees with opioid use disorder"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"105228\" class=\"elementor elementor-105228\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<div class=\"elementor-inner\">\n\t\t\t\t<div class=\"elementor-section-wrap\">\n\t\t\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-008fa8c elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"008fa8c\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t\t\t<div class=\"elementor-row\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-1919aff\" data-id=\"1919aff\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-column-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-ba01314 elementor-widget elementor-widget-text-editor\" data-id=\"ba01314\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.17.0 - 08-11-2023 *\/\n.elementor-widget-text-editor.elementor-drop-cap-view-stacked .elementor-drop-cap{background-color:#69727d;color:#fff}.elementor-widget-text-editor.elementor-drop-cap-view-framed .elementor-drop-cap{color:#69727d;border:3px solid;background-color:transparent}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap{margin-top:8px}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap-letter{width:1em;height:1em}.elementor-widget-text-editor .elementor-drop-cap{float:left;text-align:center;line-height:1;font-size:50px}.elementor-widget-text-editor .elementor-drop-cap-letter{display:inline-block}<\/style>\t\t\t\t\t<div class=\"elementor-text-editor elementor-clearfix\">\n\t\t\t\t<p><a>New guidance<\/a> from the United States Justice Department aims to help employers comply with laws protecting employees in treatment for, or recovery from, Opioid Use Disorder (OUD).<\/p><p>The DOJ\u2019s missive comes as the United States\u2019 deadly opioid epidemic continues to ravage the nation. <a href=\"https:\/\/www.cdc.gov\/opioids\/basics\/epidemic.html\">According to the Centers for Disease Control<\/a>, the number of drug overdose deaths increased nearly 5 percent from 2018 to 2019 and has quadrupled since 1999. More than 70 percent of the 70,630 drug overdose deaths reported in 2019 involved an opioid.<\/p><p>The DOJ\u2019s guidance explains how the federal Americans with Disabilities Act (ADA) protects people with OUD and seeks to remove discriminatory barriers to recovery for individuals who have completed, or are participating in, treatment for the disorder. OUD treatments under licensed medical supervision often include frequent monitoring and carefully titrated consumption of less addictive opioids, such as buprenorphine and methadone \u2014 medications that, if not used as prescribed, can cause problems in the workplace.<\/p><p>\u201cThe opioid epidemic continues to pose an extraordinary challenge to communities across our country, and the COVID-19 pandemic has exacerbated this crisis,\u201d Assistant Attorney General Kristen Clarke of the DOJ\u2019s Civil Rights Division said in a statement. \u201cPeople who have stopped illegally using drugs should not face discrimination when accessing evidence-based treatment or continuing on their path to recovery.\u201d<\/p><p>In recent months, the DOJ\u2019s Civil Rights Division has tackled several cases to help ensure people in treatment and recovery participate successfully in the workforce. Among them were three cases in March alone:<\/p>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ef64cc9 elementor-icon-list--layout-traditional elementor-list-item-link-full_width elementor-widget elementor-widget-icon-list\" data-id=\"ef64cc9\" data-element_type=\"widget\" data-widget_type=\"icon-list.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<link rel=\"stylesheet\" href=\"https:\/\/www.nationaldrugscreening.com\/wp-content\/plugins\/elementor\/assets\/css\/widget-icon-list.min.css\">\t\t<ul class=\"elementor-icon-list-items\">\n\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 262.21 300\"><defs><style>.cls-1{fill:#dcdcdc;}<\/style><\/defs><polygon class=\"cls-1\" points=\"74.43 111.58 74.43 205.78 156 252.87 237.58 205.78 237.58 111.58 156 64.48 74.43 111.58\"><\/polygon><g><path d=\"M134.2,16.45h0m-3.09,1.78L245.22,84.12V215.88L131.11,281.77,17,215.88V84.12L131.11,18.23m0-15.95a8.76,8.76,0,0,0-4.41,1.18L6.4,72.91A8.83,8.83,0,0,0,2,80.55v138.9a8.83,8.83,0,0,0,4.41,7.64l120.3,69.45a8.83,8.83,0,0,0,8.82,0l120.29-69.45a8.83,8.83,0,0,0,4.41-7.64V80.55a8.83,8.83,0,0,0-4.41-7.64L135.52,3.46a8.81,8.81,0,0,0-4.41-1.18Z\"><\/path><\/g><path d=\"M220.28,143.93,170.74,99.66a8.14,8.14,0,0,0-13.56,6.07v36.13H47.36a8.14,8.14,0,0,0,0,16.28H157.18v36.13A8.14,8.14,0,0,0,162,201.7a8,8,0,0,0,3.32.71,8.13,8.13,0,0,0,5.42-2.07l49.54-44.27a8.13,8.13,0,0,0,0-12.14Z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">The department issued a letter finding that the Indiana State Board of nursing violated the ADA by denying a nurse the chance to participate in a substance use disorder rehabilitation program because she takes medication for OUD. The program is required for the woman to reinstate her nursing license. <\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 262.21 300\"><defs><style>.cls-1{fill:#dcdcdc;}<\/style><\/defs><polygon class=\"cls-1\" points=\"74.43 111.58 74.43 205.78 156 252.87 237.58 205.78 237.58 111.58 156 64.48 74.43 111.58\"><\/polygon><g><path d=\"M134.2,16.45h0m-3.09,1.78L245.22,84.12V215.88L131.11,281.77,17,215.88V84.12L131.11,18.23m0-15.95a8.76,8.76,0,0,0-4.41,1.18L6.4,72.91A8.83,8.83,0,0,0,2,80.55v138.9a8.83,8.83,0,0,0,4.41,7.64l120.3,69.45a8.83,8.83,0,0,0,8.82,0l120.29-69.45a8.83,8.83,0,0,0,4.41-7.64V80.55a8.83,8.83,0,0,0-4.41-7.64L135.52,3.46a8.81,8.81,0,0,0-4.41-1.18Z\"><\/path><\/g><path d=\"M220.28,143.93,170.74,99.66a8.14,8.14,0,0,0-13.56,6.07v36.13H47.36a8.14,8.14,0,0,0,0,16.28H157.18v36.13A8.14,8.14,0,0,0,162,201.7a8,8,0,0,0,3.32.71,8.13,8.13,0,0,0,5.42-2.07l49.54-44.27a8.13,8.13,0,0,0,0-12.14Z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">The DOJ struck a settlement with a Massachusetts trial court to resolve allegations that its drug court violated the ADA by discriminating against individuals with OUD. <\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 262.21 300\"><defs><style>.cls-1{fill:#dcdcdc;}<\/style><\/defs><polygon class=\"cls-1\" points=\"74.43 111.58 74.43 205.78 156 252.87 237.58 205.78 237.58 111.58 156 64.48 74.43 111.58\"><\/polygon><g><path d=\"M134.2,16.45h0m-3.09,1.78L245.22,84.12V215.88L131.11,281.77,17,215.88V84.12L131.11,18.23m0-15.95a8.76,8.76,0,0,0-4.41,1.18L6.4,72.91A8.83,8.83,0,0,0,2,80.55v138.9a8.83,8.83,0,0,0,4.41,7.64l120.3,69.45a8.83,8.83,0,0,0,8.82,0l120.29-69.45a8.83,8.83,0,0,0,4.41-7.64V80.55a8.83,8.83,0,0,0-4.41-7.64L135.52,3.46a8.81,8.81,0,0,0-4.41-1.18Z\"><\/path><\/g><path d=\"M220.28,143.93,170.74,99.66a8.14,8.14,0,0,0-13.56,6.07v36.13H47.36a8.14,8.14,0,0,0,0,16.28H157.18v36.13A8.14,8.14,0,0,0,162,201.7a8,8,0,0,0,3.32.71,8.13,8.13,0,0,0,5.42-2.07l49.54-44.27a8.13,8.13,0,0,0,0-12.14Z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">The DOJ entered into another settlement agreement with a Colorado-based employment, residential and social services program that it said denied admission to a woman because she takes medication for OUD. <\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t<\/ul>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-107156d elementor-widget elementor-widget-text-editor\" data-id=\"107156d\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-text-editor elementor-clearfix\">\n\t\t\t\t<p>The DOJ emphasized that the ADA does not protect individuals \u201cengaged in the current use of illicit drugs if an entity takes action against them because of that illegal drug use.\u201d The department further defined \u201ccurrent use of drugs\u201d to mean \u201cillegal use of drugs that occurred recently enough to justify a reasonable belief that a person\u2019s drug use is current or that continuing use is a real and ongoing problem. Illegal use, however, does not include taking a medication, including an opioid or medication used to treat OUD, under the supervision of a licensed healthcare professional.\u201d<\/p><p>National Drug Screening\u2019s <a>workplace drug testing programs and services<\/a> are designed to be compliant with state and federal law and to reduce an employer\u2019s exposure to liability. Learn more about how we can help your company create a comprehensive workplace drug testing program.<\/p>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-28d7fc2 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"28d7fc2\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t\t\t<div class=\"elementor-row\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-135cbd2\" data-id=\"135cbd2\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-column-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-531a1d6 elementor-align-justify elementor-widget elementor-widget-button\" data-id=\"531a1d6\" data-element_type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"\/wp-content\/uploads\/ADA-and-SUD-Graphic-for-NDS.pdf\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon elementor-align-icon-right\">\n\t\t\t\t<svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" aria-hidden=\"true\" data-prefix=\"fas\" data-icon=\"info-circle\" class=\"svg-inline--fa fa-info-circle fa-w-16\" viewBox=\"0 0 512 512\"><path fill=\"currentColor\" d=\"M256 8C119.043 8 8 119.083 8 256c0 136.997 111.043 248 248 248s248-111.003 248-248C504 119.083 392.957 8 256 8zm0 110c23.196 0 42 18.804 42 42s-18.804 42-42 42-42-18.804-42-42 18.804-42 42-42zm56 254c0 6.627-5.373 12-12 12h-88c-6.627 0-12-5.373-12-12v-24c0-6.627 5.373-12 12-12h12v-64h-12c-6.627 0-12-5.373-12-12v-24c0-6.627 5.373-12 12-12h64c6.627 0 12 5.373 12 12v100h12c6.627 0 12 5.373 12 12v24z\"><\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"elementor-button-text\">View This PDF to Learn More About the ADA<\/span>\n\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-7338555 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"7338555\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t\t\t<div class=\"elementor-row\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-7836d2e\" data-id=\"7836d2e\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-column-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-bb3b42f dce_masking-none elementor-widget elementor-widget-image\" data-id=\"bb3b42f\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.17.0 - 08-11-2023 *\/\n.elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=\".svg\"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block}<\/style>\t\t\t\t\t<div class=\"elementor-image\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/www.nationaldrugscreening.com\/wp-content\/uploads\/ADA-and-SUD-Graphic-for-NDS-1.pdf\">\n\t\t\t\t\t\t\t<img decoding=\"async\" width=\"456\" height=\"641\" src=\"https:\/\/www.nationaldrugscreening.com\/wp-content\/uploads\/ada.png\" class=\"attachment-large size-large wp-image-105288\" alt=\"What Employers Need to Know About ADA\" srcset=\"https:\/\/www.nationaldrugscreening.com\/wp-content\/uploads\/ada.png 456w, https:\/\/www.nationaldrugscreening.com\/wp-content\/uploads\/ada-213x300.png 213w\" sizes=\"(max-width: 456px) 100vw, 456px\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>New guidance from the United States Justice Department aims to help employers comply with laws protecting employees in treatment for, or recovery from, Opioid Use Disorder (OUD). The DOJ\u2019s missive comes as the United States\u2019 deadly opioid epidemic continues to ravage the nation. According to the Centers for Disease Control, the number of drug overdose [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":105233,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"97806,51317,51165,54586,51264,50875","_relevanssi_noindex_reason":"","footnotes":""},"categories":[195],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/105228"}],"collection":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/comments?post=105228"}],"version-history":[{"count":0,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/105228\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media\/105233"}],"wp:attachment":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media?parent=105228"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/categories?post=105228"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/tags?post=105228"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}